In-vitro antibacterial activity of omeprazole and esomeprazole in combination with ciprofloxacin as an alternative to repositioning against ESKAPE pathogens and evaluation of the cleavage capacity of plasmid DNA

Int J Antimicrob Agents. 2023 May;61(5):106753. doi: 10.1016/j.ijantimicag.2023.106753. Epub 2023 Feb 10.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Ciprofloxacin / pharmacology
  • DNA
  • Esomeprazole* / pharmacology
  • Omeprazole* / pharmacology
  • Plasmids
  • Proton Pump Inhibitors / pharmacology

Substances

  • Omeprazole
  • Esomeprazole
  • Ciprofloxacin
  • Proton Pump Inhibitors
  • Anti-Bacterial Agents
  • DNA